- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
14 result(s) found for: Vaginal Ultrasonography.
Displaying page 1 of 1.
EudraCT Number: 2021-004536-28 | Sponsor Protocol Number: 1 | Start Date*: 2021-11-15 |
Sponsor Name:Uppsala University, Department of Women's and Children´s Health | ||
Full Title: Vaginal administration of selective estrogen receptor modulator (Tamoxifen) treatment to improve sexual function for women with breast cancer. A randomized, double-blinded, placebo controlled longi... | ||
Medical condition: Most troublesome vulvovaginal atrophy symptom | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000158-36 | Sponsor Protocol Number: OXYPEP202 | Start Date*: 2016-03-18 | |||||||||||
Sponsor Name:PEPTONIC medical AB | |||||||||||||
Full Title: A Phase 2b, Double-blind, Randomized, Parallel, Placebo-Controlled Study to Evaluate the 12-week Efficacy of Vagitocin in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy | |||||||||||||
Medical condition: Vaginal Atrophy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002348-42 | Sponsor Protocol Number: RG_13-151 | Start Date*: 2014-12-10 |
Sponsor Name:University of Birmingham | ||
Full Title: Effectiveness of progesterone to prevent miscarriage in women with early pregnancy bleeding: A randomised placebo-controlled trial (PRISM Trial: PRogesterone In Spontaneous Miscarriage Trial) | ||
Medical condition: Vaginal bleeding in the first 12 weeks of pregnancy. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000115-32 | Sponsor Protocol Number: EVE112-CT02-2015 | Start Date*: 2016-02-25 | |||||||||||
Sponsor Name:Evestra GmbH | |||||||||||||
Full Title: Characterization of ovulation inhibition of a new vaginal delivery system (EVE 112, Evestra/Germany) containing etonogestrel and ethinylestradiol – an open label, single centre, comparative, parall... | |||||||||||||
Medical condition: Investigation of ovulation inhibition for indication of contraception. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004664-36 | Sponsor Protocol Number: EVE116-CT03-2017 | Start Date*: 2018-06-19 |
Sponsor Name:Evestra GmbH | ||
Full Title: Characterization of ovulation inhibition of a new vaginal delivery system containing trimegestone - an open-label, single-centre study in healthy females of childbearing potential | ||
Medical condition: Investigation of ovulation inhibition for indication of contraception | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004018-44 | Sponsor Protocol Number: MIT-Do0001-C201 | Start Date*: 2016-04-08 | |||||||||||
Sponsor Name:Donesta Bioscience BV | |||||||||||||
Full Title: A Multicentre Dose-Finding, Randomised, Double-Blind, Placebo-Controlled Study to Select the Daily Oral Dose of Estetrol (E4) for the Treatment of Vasomotor Symptoms in Post-Menopausal Women. | |||||||||||||
Medical condition: Vasomotor Symptoms in Post-Menopausal Women | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) NL (Completed) PL (Completed) GB (Completed) CZ (Completed) IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005476-14 | Sponsor Protocol Number: PR3081 | Start Date*: 2007-11-09 |
Sponsor Name:Pantarhei Bioscience BV | ||
Full Title: A feasibility study into the contraceptive effect of estetrol alone or combined with either progesterone or desogestel by daily oral administration to healthy female volunteers for 28 days | ||
Medical condition: Only healthy volunteers will participate in this clinical trial. Intended indication: contraception. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-011858-17 | Sponsor Protocol Number: PR3095 | Start Date*: 2009-09-25 | |||||||||||
Sponsor Name:Pantarhei Bioscience BV [...] | |||||||||||||
Full Title: A dose finding study with an active control group (Yasmin) to assess the contraceptive efficacy and the efficacy on liver function of estetrol combined with 3 mg drospirenone by daily oral administ... | |||||||||||||
Medical condition: Only healthy premenopausal volunteers will participate in this clinical trial. Intended indication: contraception. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000964-27 | Sponsor Protocol Number: WP2018 | Start Date*: 2018-05-09 |
Sponsor Name:Karolinska Institutet | ||
Full Title: Medical termination of pregnancy from day 85 to day 153 of gestation: A randomized comparison between administration of the initial dose of misoprostol at home or in the clinic | ||
Medical condition: Unwanted pregnancy | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002700-14 | Sponsor Protocol Number: NA-0113-200-EU | Start Date*: 2018-12-14 | |||||||||||
Sponsor Name:Navad Life Sciences Pte Ltd | |||||||||||||
Full Title: Single-center, open-label, adaptive design study to evaluate the influence on hormonal and ovarian function and vaginal bleeding pattern of different dosages of levonorgestrel administered once dai... | |||||||||||||
Medical condition: Investigation of ovulation inhibition for indication of contraception | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001554-10 | Sponsor Protocol Number: NL57892 | Start Date*: 2016-06-21 | ||||||||||||||||
Sponsor Name:Radboudumc | ||||||||||||||||||
Full Title: Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: a pilot study | ||||||||||||||||||
Medical condition: Women aged above 18 years with early pregnancy failure, 6-14 weeks postmenstrual. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-003893-34 | Sponsor Protocol Number: MC2-16-C1 | Start Date*: 2016-03-16 |
Sponsor Name:Drug Delivery Solutions Aps (DDS) c/o MC2 Biotek Group | ||
Full Title: STUDY OF THE EFFICACY AND SAFETY OF A PAD™ CALCIPOTRIOL CREAM IN THE PSORIASIS PLAQUE TEST | ||
Medical condition: Psoriasis vulgaris | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-005109-23 | Sponsor Protocol Number: AWC LowE | Start Date*: 2009-08-05 | |||||||||||||||||||||
Sponsor Name:Uppsala University Hospital | |||||||||||||||||||||||
Full Title: Low-Dose Hormone Therapy Initiated early after Menopause and Changes in Artery Wall Composition (AWC), as Assesssed by High-Frequency Ultrasound. | |||||||||||||||||||||||
Medical condition: Age/menopause related changes in the artery wall composition after menopause | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002201-25 | Sponsor Protocol Number: CHDR2007 | Start Date*: 2020-12-14 |
Sponsor Name:Centre for Human Drug Research | ||
Full Title: A two-part (observational and intervention) study to explore disease characteristics of vulvar (pre)malignancies compared to healthy volunteers | ||
Medical condition: lichen sclerosus, vulvar (pre)malignancies | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.